These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38744583)

  • 1. Statin use, albuminuria, and mortality risk: Re-evaluating C-reactive protein to albumin ratio in hypertensive patients based on NHANES data.
    Hung KC; Chao CT
    Nutr Metab Cardiovasc Dis; 2024 Aug; 34(8):2016-2017. PubMed ID: 38744583
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: A national cohort study.
    Zhang R; Wang Y; Liao L; Liao Y; Fang Y; Shen Y
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1601-1609. PubMed ID: 38519295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension?
    Saylik F; Akbulut T; Kaya S
    Angiology; 2021 Nov; 72(10):947-952. PubMed ID: 33902353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between C-reactive protein/albumin ratio and all-cause mortality in patients with stroke: Evidence from NHANES cohort study.
    Yuan J; Cheng Y; Han X; Zhu N; Ma W; Li J; Jiang S; Zhao J; Liu F
    Nutr Metab Cardiovasc Dis; 2024 Oct; 34(10):2305-2314. PubMed ID: 39004593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention.
    Özyilmaz A; Boersma C; Visser ST; Postma MJ; de Jong-van den Berg LT; Lambers-Heerspink HJ; de Jong PE; Gansevoort RT
    Eur J Prev Cardiol; 2016 May; 23(8):847-55. PubMed ID: 26358992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004.
    Yoon SS; Dillon CF; Carroll M; Illoh K; Ostchega Y
    J Atheroscler Thromb; 2010 Nov; 17(11):1176-82. PubMed ID: 20805636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum.
    Ridker PM
    Circulation; 2002 Jun; 105(22):2583-5. PubMed ID: 12045159
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.
    Kokkinos P; Faselis C; Myers J; Kokkinos JP; Doumas M; Pittaras A; Kheirbek R; Manolis A; Panagiotakos D; Papademetriou V; Fletcher R
    Am J Hypertens; 2014 Mar; 27(3):422-30. PubMed ID: 24436326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal-related biomarkers and long-term mortality in the US subjects with different coronary risks.
    Wu CK; Chang MH; Lin JW; Caffrey JL; Lin YS
    Atherosclerosis; 2011 May; 216(1):226-36. PubMed ID: 21371709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammation, albuminuria, and functional disability in older adults with cardiovascular disease: the National Health and Nutrition Examination Survey, 1999-2008.
    Kuo HK; Al Snih S; Kuo YF; Raji MA
    Atherosclerosis; 2012 Jun; 222(2):502-8. PubMed ID: 22460050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank.
    Wändell P; Carlsson AC; Larsson AO; Ärnlöv J; Ruge T; Rydell A
    BMC Cardiovasc Disord; 2024 Jun; 24(1):326. PubMed ID: 38926672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of high-sensitivity assays for C-reactive protein in clinical practice.
    Musunuru K; Kral BG; Blumenthal RS; Fuster V; Campbell CY; Gluckman TJ; Lange RA; Topol EJ; Willerson JT; Desai MY; Davidson MH; Mora S
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):621-35. PubMed ID: 18711404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of soluble receptor for advanced glycation end products levels with hypertensive albuminuria.
    Zheng H; Yuan L; Xie N; Xu H; Xie X; Luo M
    Curr Vasc Pharmacol; 2015; 13(2):259-64. PubMed ID: 24329736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bicarbonate and mortality in adults in NHANES III.
    Raphael KL; Zhang Y; Wei G; Greene T; Cheung AK; Beddhu S
    Nephrol Dial Transplant; 2013 May; 28(5):1207-13. PubMed ID: 23348878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of urinary albumin-creatinine ratio and glomerular filtration rate on long-term mortality in patients with heart failure: The National Health and Nutrition Examination Survey 1999-2018.
    Xu X; Cai L; Zhu X; Wang H; Chen T; Zhu H; Lin K
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1477-1487. PubMed ID: 38418348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
    Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
    Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Different Estimates of Albuminuria in Association with Mortality in Epidemiologic Research.
    Koopman JJE; Scherzer R; Ix JH; Shlipak MG; Waikar SS
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1814-1816. PubMed ID: 32928745
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria.
    Villa-Zapata L; Warholak T; Slack M; Malone D; Murcko A; Runger G; Levengood M
    Int Urol Nephrol; 2016 Feb; 48(2):249-56. PubMed ID: 26661258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum apolipoprotein B and risk of all-cause and cardiovascular disease mortality in individuals with hypertension: a prospective cohort study.
    Huang Y; Chen S; Pan H; Yang S; Cheng W
    BMC Cardiovasc Disord; 2024 May; 24(1):273. PubMed ID: 38789961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.